Yesterday’s higher than usual volume on the penny stock of Immunovative, Inc. (IMUN) proved to many that sellers aren’t bailing out on the patent squatters. With news of a 12th patent issued to Immunovative Therapies Ltd. with whom the Company has an exclusive worldwide license with, the closer wither of the two cancer drugs get, the more
Continue Reading →
27
NOV
0
Share
